Unauthorized COVID-19 Diagnostic Test Kits Imported Without FDA Approval
SD Biosensor's STANDARD Q COVID-19 Ag Home Test kits were illegally imported without FDA approval, clearance, or authorization. Approximately 400,000 units were distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification applies. Although no illnesses or injuries have been reported, unapproved medical devices pose regulatory and potential safety risks. Per rubric, FDA Class I recalls must score at least 4 (Severe).
Plain-English summary
The STANDARD Q COVID-19 Ag Home Test is a rapid diagnostic immunoassay designed to detect SARS-CoV-2 nucleocapsid antigen in human nasal samples. Approximately 400,000 units (Lot 59628J1T1) manufactured by SD Biosensor, Inc., were imported and distributed throughout the United States.
These test kits were not approved, cleared, or authorized by the U.S. Food and Drug Administration for distribution in the United States. Their unapproved status means they have not undergone the FDA's required evaluation and authorization processes for medical devices, leaving their performance and safety unvalidated.
If you have one of these test kits, do not use it. Consult with a healthcare provider or contact the FDA for guidance regarding proper handling and disposal. For additional information, contact the FDA or your local health department.
The recalled product
- Product
- STANDARD Q COVID-19 Ag Home Test STANDARD Q COVID-19 Ag Home Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigen present in human nasal sample.
- Manufacturer
- SD Biosensor, Inc.
- Hazard
- unauthorized-medical-device
- regulatory-violation
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- HighRayCare 2024A SP4 Oncology System Beam Set Delivery Note Data Loss
FDA (Devices) · 2026-07-08
- ModerateDuoGlide Short-Term Dialysis Catheter recall due to deficient manufacturing
FDA (Devices) · 2026-07-08
- HighRayCare 2024A SP1 Oncology Information System Software Recall
FDA (Devices) · 2026-07-08
- ModeratePower-Trialysis Slim-Cath Dialysis Catheters Recalled by Bard Access Systems
FDA (Devices) · 2026-07-08
- SevereHillrom VOLARA System patient circuits recalled for nebulizer leakage risk
FDA (Devices) · 2026-07-08